Citius Pharmaceuticals, Inc. Variable Lease, Cost
Citius Pharmaceuticals, Inc. (CTXR) reported Variable Lease, Cost of $398 for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-14
- Citius Pharmaceuticals, Inc. variable lease, cost for the quarter ending 2026-06-30 was $300.00, a 86.21% decline year-over-year.
- Citius Pharmaceuticals, Inc. variable lease, cost for the quarter ending 2025-09-30 was $21.89K, a 0.87% decline year-over-year.
- Citius Pharmaceuticals, Inc. variable lease, cost for the quarter ending 2025-06-30 was $2.17K, a 72.07% increase year-over-year.
- Citius Pharmaceuticals, Inc. variable lease, cost for the quarter ending 2025-03-31 was $7.37K, a 482.83% increase year-over-year.
- Citius Pharmaceuticals, Inc. variable lease, cost for fiscal 2025 was $32.69K, a 26.67% increase from fiscal 2024.
- Citius Pharmaceuticals, Inc. variable lease, cost for fiscal 2024 was $25.81K, a 440.96% increase from fiscal 2023.
- Citius Pharmaceuticals, Inc. variable lease, cost for fiscal 2023 was $4.77K, a 518.01% increase from fiscal 2022.
- Citius Pharmaceuticals, Inc. variable lease, cost for fiscal 2022 was $772.00, a 297.94% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 6 month as first filed | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $300.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-14 | $398.00 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | $98.00 10-Q · filed 2026-05-15 | ||||
| 2025-09-30 | $21.89K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-23 | $24.06K derived: sum of 2 quarters · filed 2026-08-14 | $31.43K derived: sum of 3 quarters · filed 2026-08-14 | $32.69K 10-K · filed 2025-12-23 | |
| 2025-06-30 | $2.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-14 | $9.54K derived: sum of 2 quarters · filed 2026-08-14 | $10.81K 10-Q · filed 2026-08-14 | $32.88K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $7.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-15 | $8.63K 10-Q · filed 2026-05-15 | $30.71K derived: sum of 3 quarters · filed 2026-05-15 | $31.97K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | $1.26K 10-Q · filed 2026-02-13 | $23.34K derived: sum of 2 quarters · filed 2026-02-13 | $24.61K derived: sum of 3 quarters · filed 2026-02-13 | $25.87K derived: sum of 4 quarters · filed 2026-02-13 | |
| 2024-09-30 | $22.08K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-23 | $23.34K derived: sum of 2 quarters · filed 2025-12-23 | $24.61K derived: sum of 3 quarters · filed 2025-12-23 | $25.81K 10-K · filed 2025-12-23 | |
| 2024-06-30 | $1.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-12 | $2.53K derived: sum of 2 quarters · filed 2025-08-12 | $3.73K 10-Q · filed 2025-08-12 | $4.94K derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | $1.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14 | $2.47K 10-Q · filed 2025-05-14 | $3.67K derived: sum of 3 quarters · filed 2025-05-14 | $3.67K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $1.20K 10-Q · filed 2025-02-14 | $2.41K derived: sum of 2 quarters · filed 2025-02-14 | $2.41K derived: sum of 3 quarters · filed 2025-02-14 | $4.82K derived: sum of 4 quarters · filed 2025-02-14 | |
| 2023-09-30 | $1.20K derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-27 | $1.20K derived: sum of 2 quarters · filed 2024-12-27 | $3.61K derived: sum of 3 quarters · filed 2024-12-27 | $4.77K 10-K · filed 2024-12-27 | |
| 2023-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-14 | $2.41K derived: sum of 2 quarters · filed 2024-08-12 | $3.57K 10-Q · filed 2023-08-14 | $3.57K derived: sum of 4 quarters · filed 2024-08-12 | |
| 2023-03-31 | $2.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $3.57K 10-Q · filed 2024-08-12 | $2.36K 10-Q · filed 2023-05-12 | $3.57K derived: sum of 3 quarters · filed 2024-08-12 | |
| 2022-12-31 | $1.16K 10-Q · filed 2024-02-14 | $1.16K derived: sum of 2 quarters · filed 2024-02-14 | |||
| 2022-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-29 | $772.00 10-K · filed 2023-12-29 | |||
| 2022-06-30 | $772.00 10-Q · filed 2023-08-14 | ||||
| 2021-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-22 | $0.00 derived: sum of 2 quarters · filed 2022-12-22 | $0.00 derived: sum of 3 quarters · filed 2022-12-22 | $194.00 10-K · filed 2022-12-22 | |
| 2021-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-11 | $0.00 derived: sum of 2 quarters · filed 2022-08-11 | $194.00 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-12 | $194.00 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | $194.00 10-Q · filed 2022-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |